Quoin Pharmaceuticals Ltd...

NASDAQ: QNRX · Real-Time Price · USD
8.76
0.06 (0.69%)
At close: Jun 23, 2025, 3:54 PM
8.66
-1.14%
After-hours: Jun 23, 2025, 04:04 PM EDT
0.69%
Bid 7.8
Market Cap 5.15M
Revenue (ttm) n/a
Net Income (ttm) -10.44M
EPS (ttm) -34.62
PE Ratio (ttm) -0.25
Forward PE -0.61
Analyst Buy
Ask 9.89
Volume 13,619
Avg. Volume (20D) 291,344
Open 8.36
Previous Close 8.70
Day's Range 8.36 - 8.91
52-Week Range 5.01 - 54.95
Beta 1.78

About QNRX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol QNRX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for QNRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
1 month ago
+0%
QNRX stock has given up its prior gain. Quoin Phar... Unlock content with Pro Subscription
1 month ago
+0%
Quoin Pharmaceuticals shares are trading higher after the company announced it received FDA clearance to initiate a second whole-body QRX003 netherton syndrome clinical study.